ARID1A deletion
|
Breast Cancer
|
ARID1A deletion
|
Breast Cancer
|
talazoparib Sensitive: D – Preclinical
|
talazoparib Sensitive: D – Preclinical
|
ARID1A deletion
|
Colon Cancer
|
ARID1A deletion
|
Colon Cancer
|
talazoparib Sensitive: D – Preclinical
|
talazoparib Sensitive: D – Preclinical
|
ARID1A deletion
|
CRC
|
ARID1A deletion
|
CRC
|
M6620 Sensitive: D – Preclinical
|
M6620 Sensitive: D – Preclinical
|
ARID1A deletion
|
CRC
|
ARID1A deletion
|
CRC
|
SC0245 Sensitive: D – Preclinical
|
SC0245 Sensitive: D – Preclinical
|
ARID1A deletion
|
Gastric Cancer
|
ARID1A deletion
|
Gastric Cancer
|
SC0245 Sensitive: D – Preclinical
|
SC0245 Sensitive: D – Preclinical
|
ARID1A deletion
|
Estrogen Receptor Positive Breast Cancer
|
ARID1A deletion
|
Estrogen Receptor Positive Breast Cancer
|
fulvestrant Resistant: D – Preclinical
|
fulvestrant Resistant: D – Preclinical
|